Loading
Latest filing published 03 Jan 2021 for Recipharm AB (publ). Read the official filing
No signal scores available.
All filings by Thomas Eldered on record concern Recipharm AB (publ). The record holds 2 filings, all for trades on 31 December 2020.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 3 January 2021 came the latest disclosure, a transaction in Recipharm AB (publ). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations